The persistence of Epstein-Barr virus in the gastric mucosa in patients with chronic <i>Helicobacter pylori</i>-induced gastritis with gastric erosions and the effect on the course of the disease depending on the therapy
The leading etiological factor of chronic gastritis is Helicobacter pylori infection. Herpesvirus infection can take part in the development and maintenance of the inflammatory process in the gastric mucosa. A special place among herpesviruses is occupied by the Epstein–Barr virus, 95% of the popula...
Saved in:
| Main Authors: | E. E. Dubskaya, T. E. Afanasenkova, S. M. Bazhenov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Open Systems Publication
2021-11-01
|
| Series: | Лечащий Врач |
| Subjects: | |
| Online Access: | https://journal.lvrach.ru/jour/article/view/825 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of cycloferon in the treatment of chronic Helicobacter pyloriinduced gastritis with gastric erosions associated with Epstein – Barr virus
by: T. E. Afanasenkova, et al.
Published: (2022-02-01) -
The results of the effectiveness of pharmaceutical treatment of chronic gastritis with erosions associated with <i>Helicobacter pylori</i>with azithromycin and amoxicillin in the elderly
by: T. E. Afanasenkova, et al.
Published: (2024-04-01) -
Morphofunctional state of the gastric mucosa in children with chronic gastritis and the persistence of Epstein-Barr virus
by: E. P. Sitnikova, et al.
Published: (2022-07-01) -
Distribution and Clinical Impact of <i>Helicobacter pylori</i> Virulence Factors in Epstein–Barr-Virus-Associated Gastric Cancer
by: Jin Hee Noh, et al.
Published: (2025-06-01) -
Rebamipide during chronic gastritis: <i>H. pylori</i> eradication therapy and restoration of gastric mucosa barrier function
by: Т. L. Lapina, et al.
Published: (2024-01-01)